Pathogen Analysis of Central Nervous System Infections in a Chinese Teaching Hospital from 2012–2018: A Laboratory-based Retrospective Study

Abstract

Central nervous system (CNS) infections are associated with high mortality rates. The clinical presentation of many CNS infections by different pathogens is difficult to distinguish, but the definite diagnosis of the etiology is critical for effective therapy and prognosis. The aim of this study was to explore the etiology of CNS infections with definite diagnoses based on data from a clinical microbiology laboratory in Tongji Hospital, a teaching hospital in China, obtained over a six-year period. We conducted a retrospective study on all cerebrospinal fluid (CSF) specimens submitted to our clinical microbiology laboratory from September, 2012 to December, 2018. The etiology of CNS infections caused by Cryptococcus neoformans, Mycobacterium tuberculosis and common bacteria was analyzed. Antimicrobial susceptibility testing was conducted on all isolates. The results showed that 1972 cases of CNS infections were identified from 18 300 CSF specimens. Common bacterial meningitis (BM), cryptococcal meningitis (CM) and tuberculous meningitis (TM) accounted for 86.3% (677/785), 9.4% (74/785) and 4.3% (34/785) respectively of cases over the six-year period. BM was the most common among the different age groups, followed by CM. Of the TM cases, 44.1% (15/34) were distributed within the age group of 15–34 years, whereas for CM cases, 52.7% (39/74) occurred within the 35–54-year age group, and the age distribution of BM cases was fairly even. Among the bacterial pathogens isolated, Staphylococcus epidermidis was the most common, accounting for 12.5% (98/785), followed by Acinetobacter baumannii (ABA) and Staphylococcus aureus (SAU), accounting for 11.8% (93/785) and 7.6% (60/785) respectively. The resistance rates to antibiotics were >75%, with the exception of the resistance rate of ABA to tegafycline, which was <3%. More than 60% of SAU strains displayed resistance to penicillin, oxacillin, ampicillin/sulbactam, cefazolin, cefuroxime, gentamycin, tobramycin, erythromycin and levofloxacin, whereas more than 90% of SAU strains showed susceptibility to trimethoprim/sulfamethoxazole, tegafycline, vancomycin, teicoplanin and linezolid. For C. neoformans, the susceptibility rates to amphotericin B, 5-fluorocytosine, fluconazol and voriconazole were >95%. Analysis of samples from patients with CNS infection in a clinical microbiology laboratory at a teaching hospital in China over a six-year period indicated that the most common etiological agents were the bacteria ABA and SAU. The antibiotic resistance levels of ABA were found to be high and of concern, whereas isolates of C. neoformans were found to be sensitive to antifungal antibiotics.

Keywords

central nervous system infection / bacterial meningitis / cryptococcal meningitis / tuberculous meningitis / antimicrobial resistance

References

[1] HeT, KaplanS, KambojM, et al.. Laboratory Diagnosis of Central Nervous System Infection. Cur Infect Dis Rep, 2016, 18(11): 35

[2] JohnCC, CarabinH, MontanoSM, et al.. Global research priorities for infections that affect the nervous system. Nature, 2015, 527(7578): S178-S186

[3] DunbarSA, EasonRA, MusherDM, et al.. Microscopic examination and broth culture of cerebrospinal fluid in diagnosis of meningitis. J Clin Microbiol, 1998, 36(6): 1617-1620

[4] PolageCR, PettiCA. Assessment of the utility of viral culture of cerebrospinal fluid. Clin Infect Dis, 2006, 43(12): 1578-1579

[5] UbukataK. Rapid identification of meningitis due to bacterial pathogens. Rinsho Shinkeigaku (Japanese), 2013, 53(11): 1184-1186

[6] van de BeekD, CabellosC, DzupovaO, et al.. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect, 2016, 22(Suppl3): S37-S62

[7] GlimakerM, JohanssonB, GrindborgO, et al.. Adult bacterial meningitis: earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture. Clin Infect Dis, 2015, 60(8): 162-1169

[8] ScheldWM, KoedelU, NathanB, et al.. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis, 2002, 186(Suppl2): S225-S233

[9] AdrianiKS, van de BeekD, BrouwerMC, et al.. Community-acquired recurrent bacterial meningitis in adults. Clin Infect Dis, 2007, 45(5): e46-e51

[10] OkikeIO, RibeiroS, RamsayME, et al.. Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study. Lancet Infect Dis, 2014, 14(4): 301-307

[11] HarrisonLH, TrotterCL, RamsayME. Global epidemiology of meningococcal disease. Vaccine, 2009, 27(Suppl2): B51-B63

[12] BijlsmaMW, BrouwerMC, KasanmoentalibES, et al.. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis, 2016, 16(3): 339-347

[13] McGillF, HeydermanRS, PanagiotouS, et al.. Acute bacterial meningitis in adults. Lancet, 2016, 388(10063): 3036-3047

[14] MartinNG, SadaranganiM, PollardAJ, et al.. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study. Lancet Infect Dis, 2014, 14(5): 397-405

[15] GrayKJ, BennettSL, FrenchN, et al.. Invasive group B streptococcal infection in infants, Malawi. Emerg Infect Dis, 2007, 13(2): 223-229

[16] IregbuKC, ElegbaOY, BabaniyiIB. Bacteriological profile of neonatal septicaemia in a tertiary hospital in Nigeria. Afr Health Sci, 2006, 6(3): 151-154

[17] KayangeN, KamugishaE, MwizamholyaDL, et al.. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatr, 2010, 10: 39

[18] MeharV, YadavD, SomaniP, et al.. Neonatal sepsis in a tertiary care center in central India: microbiological profile, antimicrobial sensitivity pattern and outcome. J Neonatal Perinatal Med, 2013, 6(2): 165-172

[19] ClinicalLaboratory Standards Institute.. Performance Standards for Antimicrobial Susceptibility Testing, Twenty-eighth Informational Supplement, M100-S28, 2018, Wayne, PA, Clin Lab Stand Institute

[20] BritzE, PerovicO, von MollendorfC, et al.. The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 20092012. PloS one, 2016, 11(9): e0163036

[21] GuoLY, LiuLL, LiuY, et al.. Characteristics and outcomes of cryptococcal meningitis in HIV seronegative children in Beijing, China, 2002–2013. BMC Infect Dis, 2016, 16(1): 635

[22] DenkingerCM, SchumacherSG, BoehmeCC, et al.. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2014, 44(2): 435-446

[23] BilalA, TahaMK, CaeymaexL, et al.. Neonatal Meningococcal Meningitis In France From 2001 To 2013. Pediatr Infect Dis J, 2016, 35(11): 1270-1272

[24] HeydariB, KhaliliH, KarimzadehI, et al.. Clinical, Paraclinical, and Antimicrobial Resistance Features of Community-Acquired Acute Bacterial Meningitis at a Large Infectious Diseases Ward in Tehran, Iran. Iran J Pharm Res, 2016, 15(1): 347-354

[25] GuoJ, ZhouJ, ZhangS, et al.. A case-control study of risk factors for HIV-negative children with cryptococcal meningitis in Shi Jiazhuang, China. BMC Infect Dis, 2012, 12: 376

[26] McKenneyJ, BaumanS, NearyB, et al.. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986–2012. Clin Infect Dis, 2015, 60(6): 959-965

[27] BowenLN, SmithB, ReichD, et al.. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol, 2016, 12(11): 662-674

[28] RheinJ, MorawskiBM, HullsiekKH, et al.. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study. Lancet Infect Dis, 2016, 16(7): 809-818

[29] ThwaitesGE, van ToornR, SchoemanJ. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol, 2013, 12(10): 999-1010

[30] MaraisS, ThwaitesG, SchoemanJF, et al.. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010, 10(11): 803-812

[31] Morfin-OteroR, NoriegaER, DowzickyMJ. Antimicrobial susceptibility trends among grampositive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial. Ann Clin Microbiol Antimicrob, 2015, 14: 53